Skip to content

Clinical Study on Yiqi Sizi Powder in Promoting Gastrointestinal Function Recovery after Gynecological Abdominal Operation

Clinical Study on Yiqi Sizi Powder in Promoting Gastrointestinal Function Recovery after Gynecological Abdominal Operation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003416
Enrollment
Unknown
Registered
2020-06-21
Start date
2020-07-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Gastroinetestinal Dysfuction

Interventions

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Case source: The observed cases were all hospitalized in the gynecology department of Guangdong Traditional Chinese Medicine Hospital and were selected for laparoscopic surgery. 1. Gynecological laparoscopic patients: (1) Gynecological laparoscopic surgery. (2) Age: between 18-70 years old. (3) Those with 1-4 hours of operation time. (4) Those who have anesthesia for 1.5-4.5 hours. (5) TCM syndrome type belongs to qi stagnation and qi deficiency. (6) Those with informed consent. 2. Healthy people: (1) Women who have not undergone major surgery. (2) Age: between 18-70 years old. (3) No basic diseases, no severe combined diseases such as hypertension, diabetes, cardiovascular, liver, kidney, brain, lung, etc. (4) Those with informed consent.

Exclusion criteria

Exclusion criteria: 1. Gynecological laparoscopy patients: 1) Malignant tumors require extensive radical resection/enterostomy or those with advanced cachexia and extreme debilitation. 2) Those with combined diseases such as heart, liver, kidney, brain, diabetes, hypertension, etc. who cannot be controlled by treatment and have obvious symptoms.3) Patients with obvious gastrointestinal dysfunction before surgery; 4) Patients with skin disease at the treatment site; those with mental illness, allergy to treatment drugs, pregnant women or lactating women. 5) For patients with moderate or above malnutrition, serum albumin < 27g/L; or prealbumin < 0.14g/L. 6) Those who have abdominal surgery again and severe intestinal adhesions. 7) Those whose intraoperative blood loss exceeds 400 ml, or who need blood transfusion. 8) Those with serious complications within 6 hours after surgery. 9) Those who require intraperitoneal hot perfusion after surgery. 10) Drugs or treatments that have a significant effect on gastrointestinal function must be used after surgery. 11) Patients who are currently participating in or have participated in other clinical trials within 1 month prior to this study. 12) The investigator considers it inappropriate to conduct this clinical research. 2. Healthy people: the researchers believe that this clinical research is not suitable.

Design outcomes

Primary

MeasureTime frame
Gastrointestinal motility evaluation (defecation, exhaust, bowel sounds);

Countries

China

Contacts

Public ContactHuang Ziyan

Guangdong Provincial Hospital of Chinese Medicine

hzy3710@163.com+86 13631354474

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026